![]() |
市场调查报告书
商品编码
1802940
全球脑机介面市场:2032 年预测-按产品、组件、技术、应用、最终用户和地区进行分析Brain-Computer Interface Market Forecasts to 2032 - Global Analysis By Product (Invasive BCI, Partially Invasive BCI and Non-Invasive BCI), Component (Hardware, Software & Algorithms and Service), Technology, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球脑机介面市场预计在 2025 年达到 31.3 亿美元,到 2032 年将达到 107.9 亿美元,预测期内的复合年增长率为 19.35%。
脑机介面 (BCI) 是最尖端科技消除了传统的神经肌肉通路,实现了人脑与外部设备之间的直接通讯。透过读取和分析来自感测器的神经讯号,BCI 可以将大脑活动转化为操作电脑、轮椅、义肢甚至机器人系统的命令。由于 BCI 提供了恢復行动能力和沟通能力的新方法,这项技术在医疗行业中具有巨大潜力,特别是对于患有神经病变、瘫痪和言语障碍的人群。作为未来人机互动的主要力量,BCI 的应用研究不仅限于医疗领域,也扩展到游戏、防御和人机整合等领域。
据美国食品药物管理局(FDA)称,永久性临床BCI植入的数量预计将在未来一年内增加一倍以上,但目前安装的数量不到100个。
神经系统疾病增加和人口老化
推动 BCI 市场发展的主要因素之一是人口老化和帕金森氏症、阿兹海默症、癫痫和肌萎缩侧索硬化症 (ALS) 等神经系统疾病的盛行率上升。限制行动和沟通的神经退化性疾病和运动障碍在老年人中很常见。 BCI 提供了一种恢復失去能力的创造性方法,让患者可以使用思维主导的命令与周围环境互动。人口老化也刺激了对辅助科技的长期需求,特别是在医疗保健系统高度发展的地区。此外,对高效復健和沟通工具的需求,再加上全球神经病变的持续增加,正在推动 BCI 的普及。
讯号复杂性和技术限制
脑波讯号高度复杂、动态变化且易受外界干扰,准确解码这些讯号对脑机介面 (BCI) 构成了重大的技术挑战。虽然侵入式技术精度高,但也存在显着的健康风险;而脑电图 (EEG) 等非侵入式技术通常信噪比较低,导致反应不准确或延迟。个体脑活动的差异进一步增加了校准的复杂性,并降低了系统的可靠性。此外,这些技术障碍阻碍了 BCI 解决方案的广泛应用,限制了扩充性,并限制了其在临床或受控研究环境之外的应用。
扩大医疗保健以外的用途
虽然脑机介面 (BCI) 在医疗产业的应用最为普遍,但其应用也有很多机会扩展到其他产业,包括游戏、智慧家庭自动化、国防和教育。脑机介面可以创造思维控制的身临其境型游戏体验,彻底改变互动娱乐。国防应用包括提高战斗中的情境察觉,并为士兵提供通讯工具。在课堂上,脑机介面可以用来支援残疾学生、监控注意力并客製化教学内容。同时,与物联网设备的整合可以实现透过脑波讯号直接控製家用电器。
与其他技术的竞争
脑机介面 (BCI) 市场也面临其他最尖端科技的竞争,这些技术无需侵入式复杂操作即可提供类似的优势。例如,人工智慧辅助设备、眼动追踪系统、手势控制以及先进的语音辨识工具已经提供了高效的通讯和行动解决方案。这些替代方案通常应用范围更广、更易于使用且价格更低,因此对患者和看护者更具吸引力。此外,除非脑机介面 (BCI) 能够在成本效益、安全性和易用性方面展现出优于其他替代方案的明显优势,否则其应用可能会停滞不前。这种竞争压力可能会限制市场占有率,并阻碍长期成长前景。
新冠疫情以多种方式影响了脑机介面 (BCI) 市场,既带来了挑战,也带来了机会。一方面,封锁和限制措施扰乱了临床试验、推迟了产品开发、延缓了择期神经外科手术,阻碍了侵入式 BCI 的普及。供应链中断也影响了生产计划和硬体供应。然而,疫情加速了数位医疗的普及,并凸显了远距神经病学、远端监控以及为沟通和行动不便患者提供先进辅助技术的需求。穿戴式非侵入式 BCI 作为一种安全的居家心理健康、復健和远端通讯解决方案,其受欢迎程度为该行业提供了持续的成长动力。
预计非侵入式 BCI 市场在预测期内将占据最大份额
预计非侵入式脑机介面 (BCI) 领域将在预测期内占据最大的市场占有率。这主要是因为与侵入式或半侵入式系统相比,它们安全、价格低廉且易于使用。非侵入式脑机介面 (BCI) 正变得越来越适用于临床和消费应用,因为它们使用脑电图 (EEG) 和功能性近红外线光谱 (fNIRS) 等技术来记录脑波讯号,而无需手术植入。它们在游戏、心理健康护理和智慧家庭控制等非医疗领域以及沟通辅助和復健等医疗领域也越来越受欢迎。
功能性近红外线光谱 (fNIRS) 领域预计将在预测期内以最高复合年增长率成长
功能性近红外线光谱 (fNIRS) 领域预计将在预测期内实现最高成长率,因为它作为一种可携式、经济实惠、非侵入式的神经成像方法的应用日益广泛。 fNIRS 是一种比 fMRI 和 MEG 等笨重且昂贵的脑活动检测法设备更安全、更实用的替代方案。 fNIRS 的便携性、易用性和对实际应用的适用性使其在復健、认知训练、心理健康监测和人机互动方面极具吸引力。此外,随着消费者、医疗保健和教育领域对可穿戴且用户友好的脑机介面 (BCI) 的需求日益增长,fNIRS 正迅速成为首选技术。
在预测期内,北美预计将占据最大的市场占有率,这得益于其在神经技术研究方面的大量投资、先进的医疗基础设施以及强大的技术生态系统。众多领先企业、新兴企业和学术机构积极开发用于临床和消费者的侵入式和非侵入式脑机介面 (BCI),是推动这一成长的关键因素。政府资助、监管支持以及神经病变患者对辅助技术日益增长的需求,进一步加速了辅助技术的采用。此外,该地区的高认知度、尖端医疗设备的快速普及以及学术机构、医疗机构和高科技公司之间的合作,进一步增强了该地区的优势,使北美成为脑机介面商业化的全球领导者。
预计亚太地区将在预测期内呈现最高的复合年增长率,这得益于神经系统疾病的增多、医疗基础设施的快速发展以及中国、日本、韩国和印度等国家对神经技术研究投入的不断增加。地方政府和私人公司正在积极资助脑机介面(BCI)的开发,以促进自主创新生态系统,并减少对西方技术的依赖。智慧家庭、游戏和教育应用对穿戴式和非侵入式脑机介面(BCI)的需求日益增长,也进一步刺激了其应用。此外,由于人口众多、中阶医疗保健支出不断增长以及数位转型的强劲势头,亚太地区有望成为成长最快的市场。
According to Stratistics MRC, the Global Brain-Computer Interface Market is accounted for $3.13 billion in 2025 and is expected to reach $10.79 billion by 2032 growing at a CAGR of 19.35% during the forecast period. A brain-computer interface, or BCI, is a cutting-edge technology that eliminates the need for conventional neuromuscular pathways and permits direct communication between the human brain and external devices. BCIs can convert brain activity into commands that operate computers, wheelchairs, prosthetic limbs, and even robotic systems by reading and analyzing neural signals from sensors. Because it provides new means of regaining mobility and communication, this technology has enormous potential in the healthcare industry, especially for those with neurological disorders, paralysis, or speech impairments. As a major force behind future human-technology interaction, BCIs are being investigated for use in gaming, defense, and human-machine integration in addition to medical applications.
According to the U.S. Food and Drug Administration (FDA), the number of permanent clinical BCI implants is expected to more than double within the next year, although fewer than 100 such devices are currently installed.
Growing neurological disorder prevalence and aging populations
One of the main factors propelling the BCI market is the rising prevalence of neurological conditions like Parkinson's disease, Alzheimer's, epilepsy, and amyotrophic lateral sclerosis (ALS), as well as the aging population. Neurodegenerative diseases and motor impairments that limit mobility and communication are more common in older adults. BCIs offer creative ways to regain lost abilities, allowing patients to use thought-driven commands to interact with their surroundings. Long-term demand for assistive technologies is also fueled by the aging population, especially in areas with highly developed healthcare systems. Moreover, the need for efficient rehabilitation and communication tools, coupled with the ongoing global increase in neurological disorders, is driving the adoption of BCI.
Signal complexity and technical restrictions
Accurately decoding brain signals-which are extremely complex, dynamic, and prone to outside interference-presents substantial technical challenges for BCIs. While invasive techniques offer higher accuracy but come with greater health risks, non-invasive techniques, such as EEG, frequently produce low signal-to-noise ratios, which can result in inaccurate or delayed responses. Individual differences in brain activity make calibration even more difficult, which reduces the systems' dependability for widespread use. Furthermore, broad adoption of BCI solutions is being slowed down by these technical obstacles, which also restrict their scalability and prevent them from being used outside of clinical or controlled research settings.
Extending uses outside of healthcare
The adoption of BCI is still most prevalent in the healthcare industry, but there are also a lot of opportunities to expand applications to other industries like gaming, smart home automation, defense, and education. BCIs can create thought-controlled, immersive gaming experiences that revolutionize interactive entertainment. Applications for defense include improved situational awareness during combat and communication tools for soldiers. BCIs can be used in the classroom to support students with disabilities, monitor attention spans, and customize instruction. Integration with IoT devices, meanwhile, may enable direct brain signal control of household appliances.
Competition from other technologies
The market for BCI is also at risk from competition from other cutting-edge technologies that can provide comparable advantages without requiring invasive or difficult procedures. AI-powered assistive devices, eye-tracking systems, gesture-based controls, and sophisticated voice recognition tools, for example, already offer efficient communication and mobility solutions. These substitutes are more appealing to patients and caregivers because they are frequently more widely accessible, user-friendly, and less expensive. Moreover, the adoption of BCIs may stall if they are unable to show a definite advantage over alternatives in terms of cost-effectiveness, safety, and usability. This pressure from competitors may restrict market share and impede long-term growth prospects.
The COVID-19 pandemic had a mixed impact on the Brain-Computer Interface (BCI) market, creating both challenges and opportunities. On the one hand, lockdowns and restrictions hindered the adoption of invasive BCIs by interfering with clinical trials, delaying product development, and slowing elective neurosurgical procedures. Manufacturing schedules and hardware availability were also affected by supply chain disruptions. However, the pandemic hastened the adoption of digital health and brought attention to the necessity of tele-neurology, remote monitoring, and sophisticated assistive technologies for patients with communication or mobility impairments. Wearable and non-invasive BCIs attracted interest as secure, at-home options for mental health, rehabilitation, and remote communication, generating sustained growth momentum for the industry.
The non-invasive BCI segment is expected to be the largest during the forecast period
The non-invasive BCI segment is expected to account for the largest market share during the forecast period, mainly because, in contrast to invasive and partially invasive systems, it is safe, inexpensive, and simple to use. Non-invasive brain-computer interfaces (BCIs) are more accessible for clinical and consumer applications because they use technologies such as electroencephalography (EEG) and functional near-infrared spectroscopy (fNIRS) to record brain signals without the need for surgical implantation. They are becoming more and more popular in non-medical fields like gaming, mental wellness, and smart home control, as well as in healthcare for communication support and rehabilitation.
The functional near-infrared spectroscopy (fNIRS) segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the functional near-infrared spectroscopy (fNIRS) segment is predicted to witness the highest growth rate because of its increasing use as a portable, affordable, and non-invasive neuroimaging method. Blood oxygenation changes are tracked by fNIRS, a safer and more practical alternative to large, expensive modalities like fMRI or MEG for measuring brain activity. It is very appealing for rehabilitation, cognitive training, mental health monitoring, and human-computer interaction because of its portability, simplicity of use, and suitability for real-world applications. Additionally, fNIRS is quickly becoming a preferred technology as the need for wearable and user-friendly BCIs increases in the consumer, healthcare, and educational sectors.
During the forecast period, the North America region is expected to hold the largest market share, driven by its substantial investments in neurotechnology research, sophisticated healthcare infrastructure, and robust technological ecosystem. Leading businesses, start-ups, and academic institutions actively creating invasive and non-invasive BCIs for clinical and consumer use are present in the area, which is advantageous. Adoption is further accelerated by favorable government funding, regulatory support, and growing patient demand for assistive technologies among those with neurological disorders. Furthermore, the region's dominance is reinforced by high awareness, quick adoption of cutting-edge medical devices, and partnerships between academic institutions, healthcare facilities, and tech companies, making North America the world leader in BCI commercialization.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by the rise in neurological disorders in nations like China, Japan, South Korea, and India, the quick development of healthcare infrastructure; and growing investments in neurotechnology research. The development of BCI is being actively funded by regional governments and private companies in an effort to boost indigenous innovation ecosystems and lessen reliance on Western technologies. Adoption is further accelerated by the growing need for wearable, non-invasive BCIs in smart home, gaming, and educational applications. Moreover, Asia-Pacific is becoming the fastest-growing market due to its large population, rising middle-class healthcare spending, and robust digital transformation.
Key players in the market
Some of the key players in Brain-Computer Interface Market include Cadwell Industries, G.Tec Medical Enginneering Gmbh, Emotiv Systems Inc., Advanced Brain Monitoring, Inc., Natus Medical Incorporated, Compumedics, Ltd, Blackrock Neurotech Inc, Medtronic, Paradromics, Bitbrain Technologies, Nihon Kohden Corporation, Synchron, NeuroSky Inc, BrainCo, Inc., Mind Technologies, Inc and Kernel Inc.
In July 2025, Compumedics Limited announced the signing of two new 4-year distribution agreements with long-standing partners in China. The agreements, valued at A$24.4 million in total, further strengthen Compumedics' presence across key regions in Asia. The first, a A$20 million agreement, extends the Company's established partnership with its long-term Northern China distributor focused on sleep diagnostics.
In April 2025, Medtronic announced that it has entered into an agreement with Retia Medical, an innovative digital health company that develops advanced hemodynamic solutions, to distribute the Argos(TM) cardiac output monitor. The Argos(TM) monitor provides healthcare professionals with accurate hemodynamic data to support the treatment of high-risk surgical and critically ill patients.
In April 2025, Cadwell Industries has launched its latest Sierra software release providing patent-pending, synchronized ultrasound and electromyography (EMG). Combined with the Sierra Summit electrodiagnostic system and Sierra NMUS1 integrated ultrasound, the update brings electrophysiological data and ultrasound imaging together in real-time on a single screen.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.